STORAGE STABILITY OF FRESH-FROZEN PLASMA - RESULTS OF A 6-MONTH STORAGE AT -20-DEGREES-C AND -25-DEGREES-C - RING STUDY OF THE WORKING GROUP BLOOD-PLASMA CONSTITUENTS OF THE DEUTSCHE GESELLSCHAFT FUR TRANSFUSIONSMEDIZIN UND IMMUNHAMATOLOGIE (DGTI)
R. Kotitschke et al., STORAGE STABILITY OF FRESH-FROZEN PLASMA - RESULTS OF A 6-MONTH STORAGE AT -20-DEGREES-C AND -25-DEGREES-C - RING STUDY OF THE WORKING GROUP BLOOD-PLASMA CONSTITUENTS OF THE DEUTSCHE GESELLSCHAFT FUR TRANSFUSIONSMEDIZIN UND IMMUNHAMATOLOGIE (DGTI), Infusionstherapie und Transfusionsmedizin, 24(6), 1997, pp. 397-403
Background: In October 1995 the working group 'Blood Plasma Constituen
ts' of the DGTI has begun a multicenter study with three types of fres
h-frozen plasma (FFP) to determine their storage stability at four tem
peratures (-20 degrees C; -25 degrees C; -30 degrees C; -40 degrees C)
, since the European Pharmacopoeia (EP) monography on 'Human Plasma fo
r Fractionation' gives no information for its storage stability. Aim o
f the ring study was the determination of the storage stability of FFP
at four temperatures by testing characteristic plasma proteins. Mater
ial and Methods: The FFPs were manufactured by three different blood b
anks in Germany. Two FFPs were manufactured from whole blood which was
pooled and frozen in aliquots in blood bags within 6 h to 24 h after
the blood donation. The third FFP pool was manufactured from plasmaphe
resis plasma and frozen in aliquots within 4 h after the plasma donati
on. The storage stability of the FFPs was tested by measuring the acti
vity of the coagulation factors FVIII, FIX, FV and fibrinogen, the act
ivation products TAT (thrombin/antithrombin complex) and prothrombin f
ragment Fl and F2, the inhibitors antithrombin and C1-esterase inhibit
or, the IgG content, and the anti-HBs titer. 13 laboratories from Euro
pe participated in the ring study. Proteins and protein activities wer
e determined using commercial reagents. Results: The storage stability
of the FFPs was investigated for 6 months at storage temperatures -20
degrees C and -25 degrees C by testing characteristic proteins of the
Fm. The comparison of the measured values for the different proteins
tested at the beginning of the storage and after 6 months showed no si
gnificant changes of these values, with one exception, the FVIII aciti
vity of the FFP which was manufactured from whole blood and frozen wit
hin 4 h after the blood donation. The FVIII content of this plasma was
diminished by 9% compared with the starting value. Conclusion: In the
ring study of the DGTI Working Group No. 2 the investigation of the s
torage stability of the FFPs will be conducted over a time period of 3
years to allow a statement on the storage stability of these Fms afte
r this time and the influence of the different storage temperatures.